Times today:
WEEKEND ESSAY
Giving puberty blocker to ‘trans’ children is a leap into the unknown
A landmark legal review will examine claims that confused young people are being subjected to a giant medical experiment,
says Janice Turner
(extract)
These are the ethical issues which make puberty blockers the most controversial of medications. On one side are “affirmative” clinicians and trans activists who believe that halting the onset of natal puberty is the only way to alleviate the distress of gender dysphoria, a sense of being “born in the wrong body”. On the other is a growing number of psychotherapists, doctors and endocrinologists concerned that blockers are administered too readily and, since they are prescribed “off-label” with no research into the long-term outcome for patients, amount to conducting a medical experiment on children.
In recent months these brewing worries have crossed into the public sphere. A landmark judicial review is being brought by Susan Evans, a former psychiatric nurse at the Tavistock Gender Identity Development Services (GIDS), a woman known as Mrs A who is the mother of an autistic 16-year-old girl referred to the clinic, and Keira Bell, a 23-year-old woman who as a child was enabled by GIDS to transition into a male and now regrets it. The plaintiffs argue that prescribing hormone blockers to under-18s is illegal because, unable to understand their far-reaching consequences, children cannot consent to take them. They say the Tavistock is “materially misleading” child patients and their parents, omitting to say that “nearly 100 per cent of children who commence hormone blockers go on to take the irreversible cross-sex hormones”.
Meanwhile, in the light of a 3,000 per cent increase in referrals to GIDS in the past decade, the government has announced a long-awaited independent review, chaired by Dr Hilary Cass, a former president of the Royal College of Paediatrics and Child Health, to assess children’s gender services and make “evidence-based recommendations about the future use of these drugs”. (continues)
Yet her views are echoed by GIDS clinicians, 35 of whom have resigned in the past three years, many alarmed by the rush to medicalisation and the way Mermaids, Instagram trans influencers and the CBBC programme I Am Leo present transition as uncomplicated. They say they are seeing girls with a panoply of other issues — anxiety, depression, self-harm, undiagnosed autism, victims of homophobic bullying and sexual abuse — for whom transition to a male body was presented online as the universal panacea. Often a normal, tom-boyish disgust at their new breasts, eliciting sudden and unwanted sexual attention from men, is interpreted as a certainty that they are in the “wrong body”. Yet instead of interrogating these underlying issues, clinicians are told to “affirm” a young person’s “trans identity” and prescribe the puberty blockers that trans campaigners fiercely insist are their right.
The former psychiatric nurse Susan Evans, in her statement to the judicial review, says she saw triptorelin prescribed after just three or four sessions. One ex-GIDS psychotherapist tells me that getting a blockers prescription is seen as an end in itself, a sign you are truly on your trans journey. Even if a young person has already gone through puberty — so the side-effects for girls are akin to sudden menopause — they must take triptorelin for around a year before being allowed cross-sex hormones. Although this period is supposed to be a pause for reflection, young people then receive less therapy not more: “They are told, ‘Go away we’ll see you in three months’.” (continues)
www.thetimes.co.uk/article/giving-puberty-blocker-to-trans-children-is-a-leap-into-the-unknown-x3g37sb7f?wgu=270525_54264_15823125031641_208501e3fb&wgexpiry=1590088503&utm_source=planit&utm_medium=affiliate&utm_content=22278